Derm Offices Can Now Order Directly From the Brand Behind the First Glycolic Acid Patent
NEOSTRATA
On April 9, 2026, NEOSTRATA announced it'll be available for dermatology offices nationwide, including it's in‑office peels and a full maintenance skincare portfolio. NEOSTRATA, which comes with more than 50 years of clinical credibility being that it was founded by the dermatologists who developed the first glycolic acid skin patent in 1974, has been proven to deliver clinically proven results without the downtime. Some of their key offerings include: Prosystem In-Office Peels, PHA Barrier Recovery Cream and their PHA Facial Cleanser. Providers can explore and purchase products at neostrataprofessional.com, including top-performing retail essentials designed to support in-office treatments.
Boulevard Launches ePrescribe for MedSpas to Prescribe Meds Directly
BoulevardBoulevard, which is a client experience platform for appointment-based self-care businesses, announced the launch of ePrescribe — a new feature that brings secure electronic prescribing directly into patient profiles on April 14, 2026.
According to the company announcement, ePrescribe enables medspas and other clinical wellness practices to manage prescriptions alongside scheduling, charting, payments, and the broader patient experience within the Boulevard platform, eliminating system switching, reducing duplicate data entry, and minimizing risk of error.
BioPhotas Celluma Celebrates 15 Years With New LED Light Therapy Device
After celebrating its 15th anniversary on April 17 2026, therapeutic LED light therapy company, BioPhotas, Inc., launched The Celluma MYSTIQUE — a new itiration of their award-winning Celluma SERIES of Light Therapy Devices. The device is the first FDA-cleared LED mask indicated for the treatment of acne, facial wrinkles, and hair loss on the scalp all in a single device. The MYSTIQUE is available for pre-orders at Celluma.com,The Company expects to ship U.S. orders by the end of May 2026.
